Douglas E. Williams
2014 - Biogen
In 2014, Douglas E. Williams earned a total compensation of $5M as Former EVP, Research and Development at Biogen, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $859,413 |
|---|---|
| Salary | $739,112 |
| Stock Awards | $3,078,158 |
| Other | $370,365 |
| Total | $5,047,048 |
Williams received $3.1M in stock awards, accounting for 61% of the total pay in 2014.
Williams also received $859.4K in non-equity incentive plan, $739.1K in salary and $370.4K in other compensation.
Rankings
In 2014, Douglas E. Williams' compensation ranked 1,537th out of 13,032 executives tracked by ExecPay. In other words, Williams earned more than 88.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,537 out of 13,032 | 88th |
Division Manufacturing | 549 out of 4,967 | 89th |
Major group Chemicals And Allied Products | 174 out of 1,690 | 90th |
Industry group Drugs | 135 out of 1,369 | 90th |
Industry Biological Products, Except Diagnostic Substances | 19 out of 241 | 92nd |
Source: SEC filing on April 15, 2016.
Williams' colleagues
We found seven more compensation records of executives who worked with Douglas E. Williams at Biogen in 2014.
2014
George Scangos
Biogen
Chief Executive Officer
2014
Alfred Sandrock
Biogen
Chief Medical Officer
2014
Adriana Karaboutis
Biogen
EVP, Technology and Business Solutions
2014
Adam Koppel
Biogen
SVP, Chief Strategy Officer
2014
Paul Clancy
Biogen
Chief Financial Officer
2014
John Cox
Biogen
EVP, Pharmaceutical Operations and Technology
2014
Stuart Kingsley
Biogen